Found: 4
Select item for more details and to access through your institution.
A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment.
- Published in:
- Biometrical Journal, 2016, v. 58, n. 1, p. 8, doi. 10.1002/bimj.201300248
- By:
- Publication type:
- Article
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 12, p. 1405, doi. 10.1002/clc.23452
- By:
- Publication type:
- Article
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.
- Published in:
- Clinical Cardiology, 2016, v. 39, n. 10, p. 565, doi. 10.1002/clc.22565
- By:
- Publication type:
- Article
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
- Published in:
- European Heart Journal, 2016, v. 37, n. 14, p. 1145, doi. 10.1093/eurheartj/ehv466
- By:
- Publication type:
- Article